The issue of relapse in Philadelphia chromosome-positive ALL patients and how to combat this
The importance of finding strategies to prevent relapse of acute myeloid leukemia (AML)
Bispecific agents: the future of AML and MDS treatment?
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
ABVD vs. escBEACOPP in HL: a 10-year study